title: The peak impact of an Egyptain outbreak of hepatitis C virus: has it passed or has not yet occurred?
authors.forename: Azza
authors.initials: A
authors.lastname: El Sherbini
authors.forename: Shadia Abdel
authors.initials: SA
authors.lastname: Mohsen
authors.forename: Wafaa
authors.initials: W
authors.lastname: Hasan
authors.forename: Salah
authors.initials: S
authors.lastname: Mostafa
authors.forename: Khadiga
authors.initials: K
authors.lastname: El Gohary
authors.forename: Azza
authors.initials: A
authors.lastname: Moneib
authors.forename: Abdel Hamid
authors.initials: AH
authors.lastname: Abaza
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004279:DNA, Viral / Q000097:blood*; D004196:Disease Outbreaks; D004534:Egypt / Q000453:epidemiology; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000175:diagnosis* / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D016017:Odds Ratio; D015995:Prevalence; D018570:Risk Assessment; D016036:Seroepidemiologic Studies; D013997:Time Factors
chemical_list: D004279:DNA, Viral; D018937:Hepatitis C Antibodies